Your browser doesn't support javascript.
loading
A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy, C W; Forristal, J; Strife, C F; West, C D.
Afiliação
  • Clardy CW; Children's Hospital Research Foundation, Cincinnati, Ohio 45229-2899.
Clin Immunol Immunopathol ; 50(3): 333-47, 1989 Mar.
Article em En | MEDLINE | ID: mdl-2917424
The IgG fraction of serum from patients with membranoproliferative glomerulonephritis (MPGN) types I and III was found to contain a nephritic factor (NFI/III) which differed from that usually present in MPGN type II and partial lipodystrophy (NFII) in that it converts C5 and C9 as well as C3, is dependent on properdin for its activity, and requires an incubation period of several hours rather than 30 min for its demonstration. C3 conversion occurred in the absence of an intact classical pathway. This nephritic factor was found in patients with reduced serum levels of terminal components and its activity, like that of the nephritic factor in MPGN type II, correlated with the serum C3 level indicating that these nephritic factors play a large role in producing hypocomplementemia. Although potentially nephritogenic because of its ability to activate the terminal pathway, the presence of this nephritic factor did not clearly correlate with clinical course.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Inativadoras do Complemento / Fator Nefrítico do Complemento 3 / Properdina / Glomerulonefrite Membranoproliferativa / Ativação do Complemento / Via Alternativa do Complemento Limite: Humans Idioma: En Revista: Clin Immunol Immunopathol Ano de publicação: 1989 Tipo de documento: Article País de publicação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Inativadoras do Complemento / Fator Nefrítico do Complemento 3 / Properdina / Glomerulonefrite Membranoproliferativa / Ativação do Complemento / Via Alternativa do Complemento Limite: Humans Idioma: En Revista: Clin Immunol Immunopathol Ano de publicação: 1989 Tipo de documento: Article País de publicação: Estados Unidos